West Regional Oncology Director – Franchise Leader

Johnson & Johnson Innovative Medicine; Los Angeles (CA); On-site; USD 162,000 - 279,000; Full time

Benefits offered by this job

Annual bonus

Long-term incentive program

Employee benefits

Job summary

Johnson & Johnson Innovative Medicine is seeking a Regional Business Director, Oncology (West Region) – RYBREVANT Franchise, Lung & Head & Neck Cancers. This field-based leadership role directs District Managers and Sales Specialists, driving regional execution and franchise growth across multiple tumor types.

The position requires a Bachelor's degree, 10+ years in relevant roles, and 5+ years of cross-functional experience in pharma/healthcare, plus willingness to travel up to 50% and lead

Qualifications

• Bachelor's degree required.
• Valid driver’s license in one US state.
• 10+ years of relevant work experience, with 5+ years cross-functional in commercial roles within pharma/healthcare.
• Prior people management experience.
• Ability to travel up to 50% (overnight/weekend travel possible).

Responsibilities

• Lead and develop District Managers and Sales Specialists across the West Region.
• Develop and execute a West Region business plan for the RYBREVANT franchise.
• Collaborate with cross-functional partners to translate strategies into regional execution.
• Coach leaders to align internal and external stakeholders.
• Set account goals and oversee metrics and performance.

Skills

Leadership

Coaching

Team development

Strategic thinking

Communication

Education

Bachelor's degree

Job description

Johnson & Johnson Innovative Medicine is seeking a Regional Business Director, Oncology (West Region) – RYBREVANT Franchise, Lung & Head & Neck Cancers. This field-based leadership role directs District Managers and Sales Specialists, driving regional execution and franchise growth across multiple tumor types.

The position requires a Bachelor's degree, 10+ years in relevant roles, and 5+ years of cross-functional experience in pharma/healthcare, plus willingness to travel up to 50% and lead